Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,553 | -613 | -5,810 | -3,551 | -2,548 |
| Depreciation Amortization | 15 | 101 | 77 | 52 | 26 |
| Income taxes - deferred | -419 | -6,880 | N/A | N/A | N/A |
| Accounts receivable | N/A | N/A | 21 | N/A | 21 |
| Other Working Capital | -131 | 682 | 622 | 863 | 829 |
| Other Operating Activity | 10 | -193 | -233 | -501 | -380 |
| Operating Cash Flow | $-2,078 | $-6,903 | $-5,323 | $-3,137 | $-2,052 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -40 | -40 | -40 | -33 |
| Other Investing Activity | 1,400 | 0 | -12 | -12 | 0 |
| Investing Cash Flow | $1,395 | $-40 | $-52 | $-52 | $-33 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,000 | 1,000 | 0 | N/A | N/A |
| Common Stock Issued | 184 | 3,080 | 3,080 | 3,000 | N/A |
| Financing Cash Flow | $1,184 | $4,080 | $3,080 | $3,000 | $N/A |
| Beginning Cash Position | 777 | 3,640 | 3,640 | 3,640 | 3,640 |
| End Cash Position | 1,278 | 777 | 1,345 | 3,451 | 1,555 |
| Net Cash Flow | $501 | $-2,863 | $-2,295 | $-189 | $-2,085 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,078 | -6,903 | -5,323 | -3,137 | -2,052 |
| Capital Expenditure | -5 | -40 | -40 | -40 | -33 |
| Free Cash Flow | -2,083 | -6,943 | -5,363 | -3,177 | -2,085 |